Streetbeat News

Stock Prices

DRI

Darden Restaurants reported mixed Q4 results with sales growth of 6.4% YoY to $2.769 billion, slightly missing the consensus of $2.77 billion. EPS of $2.58 beat the consensus of $2.54. The company expects FY24 sales of $11.5 billion - $11.6 billion and adjusted EPS of $8.55 - $8.85. Following the announcement, TD Cowen and Wedbush raised their price targets on DRI.

Portfolio Pulse from Lisa Levin

June 23, 2023 | 11:39 am

ACN

Accenture reported Q3 FY23 revenue growth of 3% YoY to $16.57 billion, slightly beating the consensus of $16.56 billion. Adjusted EPS of $3.19 beat the consensus of $3.04. However, analysts from Piper Sandler and TD Cowen cut their price targets on Accenture following the earnings announcement.

Portfolio Pulse from Lisa Levin

June 23, 2023 | 11:34 am

PLRX

Pliant Therapeutics (PLRX) presented data from its Bexotegrast program at the EASL International Liver Congress, showcasing the potential of the drug in treating liver fibrosis.

Portfolio Pulse from Bill Haddad

June 23, 2023 | 11:32 am

NVVE

Nuvve Holding Corp has launched Astrea AI, an artificial intelligence technology to optimize revenue from ancillary services to Nordic transmission system operators from its V2G fleet customers. Astrea AI forecasts have shown 97% accuracy and help maximize revenues with the right bid matched to available fleet capacity.

Portfolio Pulse from Shivani Kumaresan

June 23, 2023 | 11:28 am

SRGA

Surgalign Holdings' shares are experiencing a significant increase on heavy trading volume.

Portfolio Pulse from Charles Gross

June 23, 2023 | 11:18 am

TSLA

In a CNBC interview, billionaire investor Ron Baron stated that he expects Tesla's stock price to reach $500 per share by 2025.

Portfolio Pulse from Charles Gross

June 23, 2023 | 11:15 am

KMX

CarMax reported better-than-expected Q1 EPS and sales results, but its shares are trading lower.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 11:10 am

GCEH

LXRX

RNAZ

Insiders at TransCode Therapeutics, Lexicon Pharmaceuticals, and Global Clean Energy Holdings have recently made significant purchases of their respective companies' shares. TransCode Therapeutics published new data supporting the use of TTX-MC138 for metastatic breast cancer treatment, Lexicon Pharmaceuticals announced the pricing of a $125 million public offering and concurrent private placement, and Global Clean Energy signed a $30 million USDA climate-smart commodities grant for its camelina project.

Portfolio Pulse from Lisa Levin

June 23, 2023 | 11:08 am

NDAQ

Nasdaq Inc has priced a public offering of $4.25 billion and €750 million senior notes to fund the acquisition of Adenza Holdings, Inc. The proceeds will also be used to repay Adenza's and its subsidiaries' outstanding debt and related expenses. The offering is expected to close on June 28, 2022.

Portfolio Pulse from Lekha Gupta

June 23, 2023 | 11:00 am

BBLN

Babylon shares are trading lower after the company agreed to be acquired by AlbaCore Capital and MindMaze Group.

Portfolio Pulse from Benzinga Newsdesk

June 23, 2023 | 10:59 am